— Know what they know.
Not Investment Advice

APYI OTC

Aspyra Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.6% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Neutral · Power 47 · $34 mcap · 107512 float · 0.026% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$15M -9.6% ▼
5Y CAGR: +19.3%
Total Liabilities
$8M +33.8% ▲
5Y CAGR: +29.8%
Shareholders Equity
$7M -35.4% ▼
5Y CAGR: +11.1%
Cash & Investments
-$348K -143.4% ▼
Total Debt
$4M +112.1% ▲
5Y CAGR: +530.7%
Net Debt
$4M +341.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2004FY2005FY2006FY2007FY2008
— Assets —
Cash$2M$1M$1M$803K-$348K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2M$1M$1M$803K-$348K
Net Receivables$2M$2M$1M$921K$807K
Inventory$86K$207K$111K$50K$27K
Other Current Assets$539K$0$1M$0$0
Total Current Assets$4M$4M$4M$2M$2M
Property, Plant & Equip.$345K$512K$1M$840K$498K
Goodwill & Intangibles$0$12M$14M$14M$13M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$2M$2M$178K$161K$210K
Total Non-Current Assets$2M$15M$16M$15M$13M
Total Assets$7M$19M$19M$17M$15M
— Liabilities —
Accounts Payable$378K$1M$887K$785K$710K
Short-Term Debt$300K$995K$2M$1M$795K
Deferred Revenue$1M$3M$2M$2M$2M
Other Current Liabilities$174K$492K$0$735K$2M
Total Current Liabilities$3M$6M$6M$6M$6M
Long-Term Debt$0$221K$0$0$3M
Other Non-Current Liab.$0$0$0$0-$198K
Total Non-Current Liabilities$0$221K$499K$348K$3M
Total Liabilities$3M$6M$6M$6M$8M
— Equity —
Common Stock$6M$17M$0$0$0
Retained Earnings-$2M-$5M-$8M-$13M-$19M
Accumulated OCI$0-$3K-$45K-$60K-$364
Total Stockholders Equity$4M$12M$13M$11M$7M
Total Liabilities & Equity$7M$19M$19M$17M$15M
— Key Metrics —
Total Debt$300K$1M$2M$2M$4M
Net Debt-$1M-$113K$1M$896K$4M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms